Pharmaceutical Market Europe • September 2024 • 35
HEALTHCARE COMMS
Emotive unveils new brand identity to reflect decade of evolution
Emotive has announced the launch of a new visual identity and branding to “reflect the agency’s evolution over the past ten years”.
The medcomms agency said the fresh identity, which has been launched alongside a new agency website, captures its “essence of inspiring change by blending deep scientific expertise with creative brilliance”.
Chris Edmonds, Emotive’s chief executive officer, explained that the agency has “significantly expanded” its team of medical writers, strategists and creatives.
He said: “With offices in the UK and US, Emotive is now a truly global medical communications agency, tackling some of the most interesting challenges in life sciences, including within the fields of rare disease, oncology and advanced therapies. We wanted to create a new brand identity that better reflected our agency and the values we hold.”
The new branding is inspired by Emotive’s energy and stability, the agency outlined. The logo is formed in weighty capitals to convey the power of engaging medical communications to spark action, while the letters are assembled vertically to create a sense of progress built upon strong and reliable foundations. The cerise pink and dark purple colours are a continuation of the agency’s previous design style, giving a nod to its heritage.
The refreshed website is intended to communicate Emotive’s “vibrant creativity fused with scientific precision” and includes a video montage showcasing some of the agency’s work, ranging from 3D animation to patient-centric campaigns and symposia, as well as its pro bono work for Medics4RareDiseases.
The site also comprises clickable links detailing the agency’s range of services across medical affairs and commercial activities, and highlights its core values.
Edmonds commented: “We wanted the design and content of the new website to showcase Emotive’s expertise and convey our personality… We pride ourselves on developing programmes that combine impactful creativity with scientific rigour, delivered by a talented and passionate team who are committed to the highest standards.”
Emotive is part of Synaptiq Health, an independent healthcare network that also includes Initiate, a market access and HEOR consultancy, and Beyond, a public relations firm.
JPA Health acquires akt health
to widen global presence
JPA Health has announced its acquisition of UK-based akt health communications to expand its global presence and enhance its medical affairs and scientific capabilities.
JPA outlined that akt’s founders Anna Radnavale, Katy Foy and Tim Cockroft will join the agency as executive directors. All akt employees will also be absorbed by JPA, bringing its staff total up to almost 150.
JPA’s chief executive officer, Carrie Jones, said: “[The agency was] delighted to welcome akt health into the growing network at JPA Health.
“While JPA Health has a strong track record supporting US and global clients, we recognise the increasing importance of the European market to our clients’ businesses.
“akt health’s deep understanding of these market complexities will be a valuable addition, enhancing our ability to deliver impactful healthcare solutions on a global scale.”
Sharing a similar sentiment, Cockroft said: “We are hugely excited to be welcomed into the JPA Health family and to bring a new depth of European and UK expertise to this growing team… Through this alliance, we look forward to offering enhanced capabilities, passion and unrivalled creativity to our clients.”
The deal follows JPA’s recent acquisition of BioCentric, which now serves as the agency’s medical communications and learning experiences arm. Sherine Aly, who founded BioCentric in 2001, continues to lead the division.
Jones said at the time of the announcement: “We are thrilled to welcome BioCentric into the growing JPA Health family. This acquisition is a great union, bringing together BioCentric’s medical prowess with JPA’s deeply rooted expertise across marketing, patient advocacy and corporate communications.”
JPA also acquired artificial intelligence-driven strategic solutions consultancy True North Solutions, led by founder Colin Baughman, towards the end of last year.
“The addition of True North Solutions, with its profound expertise in creating custom solutions rooted in data sciences, will help keep our clients ahead of their competition in connecting with target audiences and driving results,” Jones said at the time.
Carrie Jones
L-R: Katy Foy, Tim Cockroft and Anna Radnavale
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services